| A cationic nanoemulsion for the delivery of next-generation RNA vaccines LA Brito, M Chan, CA Shaw, A Hekele, T Carsillo, M Schaefer, J Archer, ... Molecular Therapy 22 (12), 2118-2129, 2014 | 365 | 2014 |
| Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes C Ciferri, S Chandramouli, D Donnarumma, PA Nikitin, MA Cianfrocco, ... Proceedings of the National Academy of Sciences 112 (6), 1767-1772, 2015 | 188 | 2015 |
| Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody S Chandramouli, C Ciferri, PA Nikitin, S Caló, R Gerrein, K Balabanis, ... Nature communications 6 (1), 8176, 2015 | 124 | 2015 |
| Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice Y Wen, J Monroe, C Linton, J Archer, CW Beard, SW Barnett, G Palladino, ... Vaccine 32 (30), 3796-3804, 2014 | 101 | 2014 |
| Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types AE Lilja, T Shenk Proceedings of the National Academy of Sciences 105 (50), 19950-19955, 2008 | 91 | 2008 |
| Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc M Cortese, S Calò, R D'Aurizio, A Lilja, N Pacchiani, M Merola PloS one 7 (11), e50166, 2012 | 68 | 2012 |
| The next generation recombinant human cytomegalovirus vaccine candidates—beyond gB AE Lilja, PW Mason Vaccine 30 (49), 6980-6990, 2012 | 61 | 2012 |
| Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies RJ Loomis, AE Lilja, J Monroe, KA Balabanis, LA Brito, G Palladino, ... Vaccine 31 (6), 919-926, 2013 | 59 | 2013 |
| A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL Y Xing, SL Oliver, TV Nguyen, C Ciferri, A Nandi, J Hickman, C Giovani, ... Proceedings of the National Academy of Sciences 112 (19), 6056-6061, 2015 | 51 | 2015 |
| Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor AE Lilja, WLW Chang, PA Barry, SP Becerra, TE Shenk Journal of virology 82 (5), 2170-2181, 2008 | 48 | 2008 |
| Additive protection against congenital cytomegalovirus conferred by combined glycoprotein B/pp65 vaccination using a lymphocytic choriomeningitis virus vector MR Schleiss, U Berka, E Watson, M Aistleithner, B Kiefmann, B Mangeat, ... Clinical and vaccine immunology 24 (1), e00300-16, 2017 | 44 | 2017 |
| Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system I Hofmann, Y Wen, C Ciferri, A Schulze, V Fühner, M Leong, A Gerber, ... Biotechnology and bioengineering 112 (12), 2505-2515, 2015 | 43 | 2015 |
| The Human Cytomegalovirus UL116 Gene Encodes an Envelope Glycoprotein Forming a Complex with gH Independently from gL S Caló, M Cortese, C Ciferri, L Bruno, R Gerrein, B Benucci, G Monda, ... Journal of Virology 90 (10), 4926-4938, 2016 | 42 | 2016 |
| Geometric and dynamic requirements for DNA looping, wrapping and unwrapping in the activation of E. coli glnAp2 transcription by NtrC AE Lilja, JR Jenssen, JD Kahn Journal of molecular biology 342 (2), 467-478, 2004 | 38 | 2004 |
| Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs P Suphaphiphat, M Franti, A Hekele, A Lilja, T Spencer, E Settembre, ... Virology journal 7, 1-5, 2010 | 33 | 2010 |
| A randomized dose-escalating phase I trial of a replication-deficient lymphocytic choriomeningitis virus vector-based vaccine against human cytomegalovirus M Schwendinger, G Thiry, B De Vos, G Leroux-Roels, J Bruhwyler, ... The Journal of infectious diseases 225 (8), 1399-1410, 2022 | 28 | 2022 |
| Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody. Nat Commun 6: 8176 S Chandramouli, C Ciferri, PA Nikitin, S Calo, R Gerrein, K Balabanis, ... | 27 | 2015 |
| Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens PP MacMaster, JL Shields, QA Alayo, C Cabral, J Jimenez, J Mondesir, ... Vaccine 35 (1), 1-9, 2017 | 21 | 2017 |
| The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains Y Yue, A Kaur, A Lilja, DJ Diamond, MR Walter, PA Barry Journal of General Virology 97 (6), 1426-1438, 2016 | 21 | 2016 |
| Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim … C Taucher, R Lazarus, H Dellago, G Maurer, P Weisova, I Corbic-Ramljak, ... Journal of Infection 87 (3), 242-254, 2023 | 10 | 2023 |
Andrea CarfiModerna IncVerified email at modernatx.com
